Publications by authors named "Ingrid Scully"

Claim this Profile
A
Adenovirus and mRNA vaccines as well as mucosal boosting improve protective efficacy against influenza virus challenge in macaques.
Catherine Jacob-Dolan, David Hope, Jinyan Liu, Alejandra Waller-Pulido, Brookelynne Verrette, Ingrid L Scully

Sci Transl Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of Nucleoside-Modified Messenger RNA Influenza Vaccines in Healthy Adults.
Angela Branche, Mark J Mulligan, Alok Maniar, Orlando Puente, Islamiat Oladipupo, Ingrid Scully

Vaccines (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2024 White Paper on Recent Issues in Bioanalysis: Evolution of Immunogenicity Assessment beyond ADA/NAb; Regulated Genomic/NGS Assays; Hypersensitivity Reactions; Minimum Noise Reduction; False Positive Range; Modernized Vaccine Approaches; NAb/TAb Correlation - Recommendations on Advanced Strategies for Molecular Assays and Immunogenicity of Gene Therapy, Cell Therapy, Vaccine; Biotherapeutics Immunogenicity Assessment & Clinical Relevance - Regulatory Agencies' Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell & Vaccine Therapies).
Omar Tounekti, Sandra Prior, Sarah Wassmer, Joshua Xu, Adrian Wong, Ingrid Scully

Bioanalysis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harmonization of Vaccine Ligand Binding Assays Validation.
Francis Dessy, Ivo Sonderegger, Leslie Wagner, Alessandra Buoninfante, Meenu Wadhwa, Ingrid Scully

Bioanalysis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccines.
Teresa Hauguel, Amy Sharma, Emily Mastrocola, Susan Lowry, Mohan S Maddur, Ingrid Scully

NPJ Vaccines· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 3, Single-arm Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine in Healthy Children 15 Months Through <18 Years of Age.
Jay Meyer, Peter Silas, G Laïssa Ouedraogo, Kathleen McElwee, Georgina Keep, Ingrid L Scully

Pediatr Infect Dis J· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase Three Study of the Safety and Immunogenicity of a Four-dose Series of 20-Valent Pneumococcal Conjugate Vaccine in Healthy Infants.
Shelly Senders, Nicola P Klein, Noor Tamimi, Allison Thompson, Gary Baugher, Ingrid L Scully

Pediatr Infect Dis J· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2023 White Paper on Recent Issues in Bioanalysis: EU IVDR 2017/746 Implementation/Impact, IVD/CDx/CLIA Approved Assays, High Dimensional Cytometry, Multiplexing Technologies, LBA Tissue Analysis, Vaccine Study Endpoints, Cell-Based Assays for Biomarkers, Cell Therapy and Vaccines ( - Recommendations on Development & Validation of Biomarkers, IVD, CDx, Cell-Based, Flow Cytometry, Ligand-Binding and Enzyme Assays; Advanced Critical Reagents Strategies).
Olga Kholmanskikh, Yow-Ming Wang, Sarah Hersey, Meenu Wadhwa, Katherine Block, Ingrid Scully

Bioanalysis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Neutrophil killing of Staphylococcus aureus in diabetes, obesity and metabolic syndrome: a prospective cellular surveillance study.
Ingrid Lea Scully, Lisa Kristin McNeil, Sudam Pathirana, Christine Lee Singer, Yongdong Liu

Diabetol Metab Syndr· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3 randomized trial of the safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in adults ≥ 60 years of age in Japan, South Korea, and Taiwan.
Miwa Haranaka, Joon Young Song, Kuo-Chin Huang, Richard de Solom, Masako Yamaji, Ingrid Scully

Vaccine· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Longitudinal Study of Group A Streptococcal Colonization and Pharyngitis in US Children.
Robert W Frenck, France Laudat, John Liang, Donna Giordano-Schmidt, Kathrin U Jansen, Ingrid L Scully

Pediatr Infect Dis J· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of pneumococcal immunogenicity elicited by the PCV13 and PCV15 vaccines in adults 18 through 49 years of age.
Isis Kanevsky, Naveen Surendran, Kathleen McElwee, Lanyu Lei, Wendy Watson, Ingrid Scully

Vaccine· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2022 White Paper on Recent Issues in Bioanalysis: Enzyme Assay Validation, BAV for Primary End Points, Vaccine Functional Assays, Cytometry in Tissue, LBA in Rare Matrices, Complex NAb Assays, Spectral Cytometry, Endogenous Analytes, Extracellular Vesicles - Recommendations on Biomarkers/CDx, Flow Cytometry, Ligand-Binding Assays Development & Validation; Emerging Technologies; Critical Reagents Deep Characterization.
Giane Sumner, Steve Keller, James Huleatt, Roland F Staack, Leslie Wagner, Ingrid Scully

Bioanalysis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a Novel Keto Sugar Component in Streptococcus pneumoniae Serotype 12F Capsular Polysaccharide and Impact on Vaccine Immunogenicity.
Kelly Sackett, Paul Brown, Kaushik Dutta, Ingrid L Scully, Seema Gangolli

J Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years.
Patricia Winokur, Juleen Gayed, David Fitz-Patrick, Stephen J Thomas, Oyeniyi Diya, Ingrid L Scully

N Engl J Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years.
Brandon Essink, Charu Sabharwal, Kevin Cannon, Robert Frenck, Himal Lal, Ingrid L Scully

Clin Infect Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Streptococcus pneumoniae serotype 15B polysaccharide conjugate elicits a cross-functional immune response against serotype 15C but not 15A.
Li Hao, Michelle M Kuttel, Neil Ravenscroft, Allison Thompson, A Krishna Prasad, Ingrid L Scully

Vaccine· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination.
Kevin Cannon, Charles Elder, Mariano Young, Daniel A Scott, Ingrid L Scully

Vaccine· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults.
Miwa Haranaka, James Baber, Yoichiro Ogama, Masako Yamaji, Masakazu Aizawa, Ingrid Scully

Nat Commun· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternal immunization with Group B Streptococcus six-valent polysaccharide conjugate vaccine supported by lack of toxicity in rat and rabbit fertility and developmental toxicity studies.
Natasha R Catlin, Gregg D Cappon, Scott Engel, Cynthia Rohde, William S Nowland, Ingrid Scully

Birth Defects Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age.
Nicola P Klein, Paula Peyrani, Kari Yacisin, Nicole Caldwell, Xia Xu, Ingrid L Scully

Vaccine· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase 1/2 study of the safety and immunogenicity of a multivalent pneumococcal conjugate vaccine in healthy adults 50 through 85 years of age.
Brandon Essink, James Peterson, Kari Yacisin, Himal Lal, Sarah Mirza, Ingrid L Scully

Hum Vaccin Immunother· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase 1 study of the safety and immunogenicity of 2 novel pneumococcal conjugate vaccines in healthy Japanese adults in the United States.
David Fitz-Patrick, Mariano Young, Daniel A Scott, Ingrid L Scully, Gary Baugher

Hum Vaccin Immunother· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BNT162b vaccines protect rhesus macaques from SARS-CoV-2.
Annette B Vogel, Isis Kanevsky, Ye Che, Kena A Swanson, Alexander Muik, Ingrid L Scully

Nature· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and T1 T cell responses.
Ugur Sahin, Alexander Muik, Evelyna Derhovanessian, Isabel Vogler, Lena M Kranz, Ingrid L Scully

Nature· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis